financetom
Market
financetom
/
Market
/
Swarmer, Lululemon, Oklo, Trade Desk And Rocket Lab: Why These 5 Stocks Are On Investors' Radars Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Swarmer, Lululemon, Oklo, Trade Desk And Rocket Lab: Why These 5 Stocks Are On Investors' Radars Today
Mar 17, 2026 6:25 PM

Major U.S. indices closed higher on Tuesday, with the Dow Jones Industrial Average edging up 0.1% to 46,993.26, the S&P 500 gaining 0.25% to 6,716.09, and the Nasdaq advancing 0.47% to 22,479.52.

These are the top stocks that gained the attention of retail traders and investors through the day:

Swarmer Inc. 

Swarmer’s stock surged 520.00% to close at $31, with an intraday high of $40 and a low of $11.25. The stock’s 52-week range is between $11.25 and $40. In the after-hours trading, the stock shot up 44.37% to $44.75.

The significant rise follows the announcement of its initial public offering pricing, drawing substantial investor interest. Swarmer Inc. priced its initial public offering at $5.00 per share, offering 3 million shares to raise approximately $15 million in gross proceeds. The company also granted underwriters a 30-day option to purchase up to an additional 450,000 shares.

Lululemon Athletica Inc. ( LULU ) 

Lululemon’s stock dipped 0.40% to $159.27, reaching a high of $164.03 and a low of $158.87. The 52-week high and low are $348.50 and $156.64, respectively. In the after-hours trading, the stock fell 1.72% to $156.52.

The company reported fourth-quarter earnings of $5.01 per share and revenue of $3.64 billion, beating estimates of $4.79 per share and $3.59 billion, respectively. Revenue rose about 1% year over year, with international growth offsetting declines in the Americas.

For fiscal 2026, the company expects GAAP EPS of $12.10 to $12.30 and revenue of $11.35 billion to $11.5 billion, both below analyst estimates of $12.67 per share and $11.53 billion. Shares declined in extended trading following the report.

Oklo Inc. ( OKLO ) 

Oklo’s stock rose 1.41% to $60.53, with a high of $65.97 and a low of $59.24. The 52-week range is $17.42 to $193.84. The stock fell 2.21% to $59.19 in extended trading.

The increase follows the company’s announcement of Department of Energy approval for its isotope facility, despite missing fourth-quarter estimates.

Oklo ( OKLO ) reported a fourth-quarter 2025 loss of 27 cents per share, missing analyst estimates for a 16-cent loss. The pre-revenue company posted operating losses of $139.3 million for 2025 and ended the period with about $788.45 million in cash and cash equivalents and $439.53 million in marketable securities.

The Trade Desk Inc. ( TTD ) 

The Trade Desk’s stock fell 7.42% to $25.07, with a high of $28.64 and a low of $24.82. Its 52-week range is $21.08 to $91.45. In the after-hours trading, the stock dipped 1.04% to $24.81.

The Trade Desk ( TTD ) shares moved higher as investors reacted to a mix of technical strength, insider buying and potential AI-related partnerships. The stock traded about 8.7% above its 20-day moving average, while short interest declined to 46.29 million shares, or 10.57% of float.

CEO Jeff Green boosted sentiment after purchasing roughly 6.4 million shares worth about $148.1 million. Additional optimism came from reports that OpenAI is in early talks with Trade Desk ( TTD ) around using its platform for ad sales, contributing to the stock's recent strength.

Rocket Lab USA Inc. 

Rocket Lab’s stock climbed 10.21% to $78.59, with an intraday high of $78.67 and a low of $71.27. The 52-week high and low are $99.58 and $14.72. In the after-hours session, the stock fell 4.89% to $74.75.

Rocket Lab ( RKLB ) shares moved lower in after-hours trading after the company filed for a potential offering of up to $1 billion in common stock. The company said proceeds would be used to fund growth initiatives, including acquisitions, as well as for general corporate purposes and working capital.

Benzinga Edge Stock Rankings show Rocket Lab ( RKLB ) stock has a Momentum in the 97th percentile.

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today
Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today
Sep 29, 2025
U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The S&P 500 added 0.26% to close at 6,661.21, while the Dow Jones Industrial Average edged up 0.15% to 46,316.07. These are the top stocks that gained the attention of retail traders and investors throughout the day. Wolfspeed Inc. ( WOLF )  Wolfspeed’s stock skyrocketed...
Technology Helps Push US Equity Indexes Higher; Gold Hits Record Amid Government Shutdown Concerns
Technology Helps Push US Equity Indexes Higher; Gold Hits Record Amid Government Shutdown Concerns
Sep 29, 2025
04:57 PM EDT, 09/29/2025 (MT Newswires) -- US equity indexes rose at the close on Monday amid gains in technology and consumer discretionary, while gold scaled a new peak ahead of a potential partial shutdown of the federal government. The Nasdaq Composite advanced 0.5% to 22,591.2, the S&P 500 rose 0.3% to 6,661.2, and the Dow Jones Industrial Average climbed...
Eupraxia Pharmaceuticals Up 20% After Hours Following 'Positive' Data From Eosinophilic Esophagitis Trial
Eupraxia Pharmaceuticals Up 20% After Hours Following 'Positive' Data From Eosinophilic Esophagitis Trial
Sep 29, 2025
05:29 PM EDT, 09/29/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) was last seen up 20% in after-hours New York trading after the company released positive results from the highest-dose cohort in the ongoing RESOLVE trial in Eosinophilic Esophagitis. Data from cohort 9 of the dose escalation part of the study showed that patients receiving an 8 milligram dose...
Equities Edge Higher in Choppy Trade; Potential Government Shutdown in Focus
Equities Edge Higher in Choppy Trade; Potential Government Shutdown in Focus
Sep 29, 2025
05:05 PM EDT, 09/29/2025 (MT Newswires) -- US equities rose after a choppy Monday session as markets weighed the prospects and implications of a potential federal government shutdown that could delay crucial economic data, including September's jobs report due later in the week. The Nasdaq Composite rose 0.5% to 22,591.2, while the S&P 500 climbed 0.3% to 6,661.2. The Dow...
Copyright 2023-2026 - www.financetom.com All Rights Reserved